June is CMV Awareness Month, and infection preventionists are urged to focus on transmission, symptoms, and prevention of this widespread yet often overlooked viral infection. During CMV Awareness ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently approved a new indication for Prevymis as a prophylaxis to prevent cytomegalovirus disease in ...

A pilot study suggests that letermovir may help prevent cytomegalovirus after lung transplant in participants with idiopathic ...

Prevymis to focus on disease in high-risk adult kidney transplant recipients. Merck & Co. has announced the FDA approval of Prevymis, a treatment for prophylaxis of cytomegalovirus (CMV) disease in ...

Cytomegalovirus (CMV) is a ubiquitous herpesvirus that persists indefinitely after primary infection, usually in a latent form in various tissues (e.g., kidney, liver, lung). [1] One percent of ...

For kidney transplant recipients, infection with a virus called cytomegalovirus may lead to devastating complications. New research suggests that extending the period of preventive treatment after ...

Letermovir is noninferior to valganciclovir for prevention of cytomegalovirus (CMV) among CMV-seronegative kidney transplant recipients who receive an organ from a CMV-seropositive donor, according to ...

Letermovir is an investigational once-daily antiviral medicine under development for the prevention of CMV infection and disease. It is a member of a new class of non-nucleoside CMV inhibitors (3,4 ...

Director of Serology and Virology Division (SAViD), Director Organ and Tissue Donor screening laboratory, Director NSW State Reference Laboratory for HIV, Chair Biosecurity Quality Assurance ...

We evaluated HDACV and pre-emptive GCV to prevent CMV disease in pediatric patients following PBSCT. During a period of almost 5 years (from May 1998 to April 2003), 76 pediatric patients with a ...

HIV-positive women with cytomegalovirus, or CMV, in their urine at the time of labor and delivery are more than five times likelier than HIV-positive women without CMV to transmit HIV, the virus that ...